Business Trends– category –
-
DalFort Capital Partners Closes Second Fund at $166 Million, Exceeding Hard Cap; Successfully Sells Polymer Adhesives Holdings
PR Newswire USA Overview DalFort Capital Partners announced the successful closing of its second fund at $166 million, exceeding its hard cap. Simultaneously, the firm announced the sale of Polymer Adhesives Holdings, a manufacturer of h... -
ORAFOL Expands U.S. Presence with Maxpro Manufacturing Acquisition, Strengthening Functional Films Business Across Value Chain
Global Legal Chronicle Germany Overview ORAFOL Europe GmbH acquired Maxpro Manufacturing, LLC, a developer and manufacturer of high-quality film solutions for automotive, architectural, and paint protection applications. This acquisition... -
tesa Celebrates 90 Years of tesafilm® with Expansion into Sustainable Production and Introduction of tesafilm® PAPER
tesa Germany Overview tesa is celebrating the 90th anniversary of its flagship product, tesafilm®, highlighting its evolution, including the recent introduction of tesafilm® PAPER. The company is investing in plant expansion for more sus... -
Japan’s Space Walker Reusable Winged Rocket “ECO ROCKET” Project Halted Due to Company Bankruptcy
CPG Click Oil and Gas Japan Overview Japan's startup Space Walker, a spin-off from Tokyo University of Science, ceased its development of the reusable winged rocket "ECO ROCKET" after the company entered bankruptcy proceedings in Februar... -
US Space Force Awards SpaceX $4.16 Billion Contract for Airborne Target Tracking Satellite Constellation, Deployment by 2028
DefenseScoop USA Overview The U.S. Space Force has awarded SpaceX a monumental $4.16 billion contract to build a satellite constellation for tracking airborne targets by 2028, as part of its Space-Based Airborne Moving Target Indicator (... -
CordenPharma Announces Multi-Million Dollar Expansion of Oligonucleotide Manufacturing to Meet Soaring Demand for Nucleic Acid-Based Medicines
Pharmaceutical Technology Europe Overview CordenPharma announced a multi-million dollar investment to significantly expand its oligonucleotide manufacturing capacity across its global network. This strategic expansion aims to meet the in... -
WuXi Biologics Completes and Prepares for Operation of New Antibody-Drug Conjugate (ADC) Manufacturing Facility
WuXi Biologics Press Release China Overview WuXi Biologics announced the successful completion and readiness for operation of its new integrated Antibody-Drug Conjugate (ADC) manufacturing facility. This expansion significantly enhances ... -
Samsung Biologics Secures Multi-Year mRNA Vaccine CDMO Partnership with Major Pharma, Leading Market Expansion
Business Korea South Korea Overview Samsung Biologics has reportedly secured a multi-year contract for large-scale mRNA vaccine manufacturing with a global pharmaceutical company. This new partnership further solidifies Samsung Biologics... -
Eli Lilly’s MASH Triple Agonist Shows Promise in Phase 2 Interim Data, Suggesting Improvement in Liver Fibrosis and Inflammation
Eli Lilly Investor Relations / MedCentral USA Overview Eli Lilly announced promising interim data from its ongoing Phase 2 trial of a triple agonist therapeutic for Metabolic Dysfunction-Associated Steatohepatitis (MASH). The data sugges... -
Kymera Therapeutics Initiates Phase 1 Clinical Trial for Oral STAT3 Degrader KT-XXX
Kymera Therapeutics Press Release USA Overview Kymera Therapeutics has announced the initiation of a Phase 1 clinical trial for its lead STAT3 degrader candidate, KT-XXX. The study aims to evaluate the safety, pharmacokinetics (PK), and ...
